Both 68Ga- and 18F-labeled tracers for imaging of prostate-specific membrane antigen (PSMA) such as [68Ga]PSMA-HBED-CC and [18F]DCFPyL have already demonstrated high potential for the detection of recurrent prostate cancer [1–4]. This evidence concerns the gene FOLH1 and prostate carcinoma.